SanfordBurnham.org > Technology > Office of Technology Management and Commercialization > Partnerships

Partnerships

Office of Technology Management and Commercialization

Global - Left Nav: Bottom Blue Border

From Research, the Power to Cure

The diseases that biomedical researchers fight are complex and require sophisticated strategies to defeat. Sanford-Burnham's multi-disciplinary approach dissects the mechanisms behind the disease from every possible angle, leading to new insights and new targets for further exploration. To maximize the potential of translating our high-impact science into important medical technology that benefits patients, Sanford-Burnham seeks highly collaborative, long-term relationships with industry. These relationships are termed "thematic collaborations." Together with partners, the Institute sets an aggressive goal and has developed multi-disciplinary projects aimed at well-defined topics.

Harnessing the power of a virtual research team

Sanford-Burnham's partners gain access to a critical mass of technology and intellectual property over an extended period of time, and are able to leverage the significant external funding that supports the research at each of the Institute's five disease-focused centers.

We are proud to partner with the following organizations

	Our partnership with Takeda Pharmaceutical Company Limited and Florida Hospital aims to discover new therapeutic approaches to obesity.
	We are collaborating with Ortho-McNeil-Janssen Pharmaceuticals, Inc., a division of Johnson & Johnson to discover new drugs to treat Alzheimer's disease and other major psychiatric disorders.
	We are partnering with Pfizer, Inc. through their Centers for Therapeutic Innovation, a research unit dedicated to open innovation through partnerships with academic research institutions.

Strengthening translational research through clinical research partnerships

The Institute is committed to translational research and has formed research partnerships with clinical organizations to advance our discoveries to the clinical research stage more quickly. These partnerships provide access to large, well-stratified patient populations for targeted clinical investigations. Our translational research bridges ensure a two-way flow of information from bench to bedside and back.

Florida Hospital

This collaboration will bridge laboratory research at Sanford-Burnham and clinical investigations at Florida Hospital to study diabetes, obesity and the metabolic origins of cardiovascular disease.
Learn More
Scripps Health

This joint translational medicine effort combines the discovery research at Sanford-Burnham with Scripps' clinical science and network of physicians and patients. It will catalyze the discovery and development of innovative new therapies and diagnostics for cancer.
Learn More

Combining the creativity of academic research and the discipline of industry

Sanford-Burnham's highly collaborative approach brings together academic researchers and scientists with extensive experience in pharmaceutical and biotechnology industries. These interdisciplinary teams are customized to address the needs of broad thematic research collaborations. We are driven by the desire to move research findings forward using a structured, disciplined approach to meet the ultimate goal of finding new treatments.

Investments that empower innovation

Sanford-Burnham has invested in sophisticated technologies for our scientists to take drug discovery to a new level. The Institute's Conrad Prebys Center for Chemical Genomics has the capacity to screen more than one million compounds per day. Investigators have access to more than 30 independent cores that provide technology and expertise in advanced research platforms.